15-valent human papillomavirus vaccine - Beijing Health Guard Biotechnology
Alternative Names: 15-Valent HPV VaccineLatest Information Update: 19 Feb 2024
Price :
$50 *
At a glance
- Originator Beijing Health Guard Biotechnology
- Developer Beijing Health Guard Biotechnology; Liaoning ChengDa Biotechnology
- Class Papillomavirus vaccines; Synthetic vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Human papillomavirus infections
Most Recent Events
- 08 Feb 2024 Beijing Health Guard Biotechnology plans a phase I trial for Human papillomavirus infections (Prevention) in China in 2024 (Beijing Health Guard Biotechnology pipeline, February 2024)
- 09 Jan 2023 Preclinical trials in Human papillomavirus infections (Prevention) in China (unspecified route) ( Beijing Health Guard Biotechnology pipeline, January 2023)